The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming - Report - MDSpire
Advertisement
The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming
Clinical Report: The Interplay of Immune and Cardiovascular Metabolism in MIRI
Overview
Myocardial ischemia-reperfusion injury (MIRI) is a significant contributor to adverse cardiac outcomes post-reperfusion therapy. This report discusses the complex interplay between immune responses and cardiac metabolism, highlighting the role of various cell types and metabolites in the injury and repair processes.
Background
MIRI is a critical factor influencing infarct size and cardiac remodeling following reperfusion therapy for acute myocardial infarction. Despite advances in treatment, effective mechanism-based therapies for MIRI remain limited. Understanding the metabolic and immune interactions during MIRI is essential for developing targeted interventions.
Data Highlights
No numerical data or trial data available in the source material.
Key Findings
MIRI is characterized by an imbalance in immune-cardiac metabolic communication rather than solely oxidative stress and inflammation.
Cardiac-resident cells actively release metabolites such as lactate, succinate, and ATP, which signal immune responses.
Infiltrating immune cells reprogram their metabolism in response to tissue-derived signals, influencing inflammation and repair.
Key mechanisms include hypoxia sensing and mitochondrial dysfunction, linking AMPK, SIRT1, and PGC-1α.
Temporal and spatial factors are crucial in understanding the dynamics of immune and metabolic interactions during MIRI.
Clinical Implications
Recognizing the immune-cardiac metabolic circuit may inform the development of therapies that target specific metabolic pathways and immune responses in MIRI. Future research should focus on time-sensitive and spatially precise interventions to improve patient outcomes.
Conclusion
The interplay between immune responses and cardiac metabolism is vital in understanding MIRI. Further exploration of these mechanisms may lead to innovative therapeutic strategies.
Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients
